6
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Photodynamic Therapy for Gastrointestinal Tumors

, , , &
Pages 20-25 | Published online: 08 Jul 2009

Reference

  • Dougherty TJ. Yearly review. Photosensitizers: therapy and detection of malignant tumors. Photochem Photobiol 1987; 45: 879–889
  • Pimstone NR. Utility of porphyrins and light in the diagnosis and treatment of malignancy. Hepatology 1985; 5: 338–340
  • Dougherty TJ. Photodynamic therapy—new approaches. Semin Surg Oncol 1989; 5: 6–16
  • Manyak M J, Russo A, Smith P D, Glatstein E. Photodynamic therapy. J Clin Oncol 1988; 6: 380–391
  • Gomer CJ. Photodynamic therapy in the treatment of malignancies. Semin Hematol 1989; 26: 27–34
  • Nakamura S, Nishikawi Y, Suzuki S, Sakaguchi S, Yamashita Y, Ohta K. Light attenuation of human liver and hepatic tumors after surgical resection. Lasers Surg Med 1990; 10: 12–15
  • Kreimer-Birnbaum M. Modified porphyrins, chlorins, phthalocyanines and purpurins: second-generation photosensitizers for photodynamic therapy. Semin Hematol 1989; 26: 157–173
  • Schuitmaker J J, van Best J A, van Delft J L, Dubbelman T M, Ooosterhuis J A, de Wolff-Rouendaal D. Bacteriochlorin a, a new photosensitizer in photodynamic therapy. In vivo results. Invest Ophthalmol Vis Sci 1990; 31: 1444–1450
  • Hayden R E, McClear P W, Morgan A R, Bischoff JK. Verdins in photodynamic therapy of squamous cell carcinoma. Am J Otolaryngol 1990; 11: 125–130
  • Castro D J, Saxton RE, Markley J, et al. Argon laser phototherapy of human malignancies using rhodamine-123 as a new laser dye: the intracellular role of oxygen. Laryngoscope 1990; 100: 884–891
  • Barr H, Tralau C J, Boulos P B, et al. Selective necrosis in dimethylhydrazine-induced rat colon tumors using phthalocyanine photodynamic therapy. Gastroenterology 1990; 98: 1532–1537
  • Reddi E, Zhou C, Biolo R, Menegaldo E, Jori G. Liposome-or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumors. I. Pharmacokinetic properties and phototherapeutic efficiency. Br J Cancer 1990; 61: 407–411
  • Mattielo J, Evelhoch J L, Brown E, Schaap A P, Hetzel FW. Effect of photodynamic therapy on RIF-1 tumor metabolism and blood flow examined by 3IP and 2H NMR spectroscopy. NMR Biomed 1990; 3: 64–70
  • West C M, West D C, Kumar S, Moore JV. A comparison of the sensitivity to photodynamic treatment of endothelial and tumour cells in different proliferative states. Int J Radial Biol 1990; 58: 145–156
  • Fingar V H, Wieman T J, Doak KW. Role of thromboxane and prostacyclin release on photodynamic therapy-induced tumor destruction. Cancer Res 1990; 50: 2599–2603
  • Henderson B W, Donovan JM. Release of prostaglandin E2 from cells by photodynamic treatment in vitro. Cancer Res 1989; 49: 6896–6900
  • Nseyo U O, Whalen R K, Duncan M R, Berman B, Lundahl SL. Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report. Urology 1990; 36: 167–171
  • Evans S, Matthews W, Perry R, Fraker D, Norton J, Pass HI. Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages. J Natl Cancer Inst 1990; 82: 34–39
  • McCaughan J S, Nims T A, Guy J T, Hicks W J, Williams T E, Laufman LR. Photodynamic therapy for esophageal tumors. Arch Surg 1989; 124: 74–80
  • Patrice T, Foultier M T, Yactayo S, et al. Endoscopic photodynamic therapy with hematoporphyrin derivative for primary treatment of gastrointestinal neoplasms in inoperable patients. Dig Dis Sci 1990; 35: 545–552
  • Thomas R J, Abbot M, Bhathal P S, St John D JB, Morstyn G. High-dose irradiation of esophageal cancer. Ann Surg 1987; 206: 193–199
  • Star W M, Levendag P C, Marijnissen J PA, et al. Fotodynamische therapie van maligne tumoren. IKR Bull 1987; 11: 3–9
  • Mullooly V M, Abramson L, Shikowitz MJ. Dihematoporphyrin ether-induced photosensitivity in laryngeal papilloma patients. Lasers Surg Med 1990; 10: 349–356
  • Dougherty T J, Cooper M T, Mang T S. Cutaneous phototoxic occurrences in patients receiving Photofrin. Lasers Surg Med 1990; 10: 485–488
  • McCaughan J S, Barabash R D, Penn G M, Glavan BJ. Nd:YAG laser and photodynamic therapy for esophageal and endobronchial tumors under general and local anesthesia. Effects on arterial blood gas levels. Chest 1990; 98: 1374–1378
  • Perry R R, Matthews W, Mitchell J B, Russo A, Evans S, Pass HI. Sensitivity of different human lung cancer histologies to photodynamic therapy. Cancer Res 1990; 50: 4272–4276
  • Dougherty TJ. Introduction. In: Bock G, Harnett S, eds. Photosensitizing compounds: their chemistry, biology and clinical use. Ciba Foundation Symposium 146. John Wiley & Sons, Chichester 1989; 1–3
  • Barr H, Krasner N, Boulos P B, Chatlani P, Bown SG. Photodynamic therapy for colorectal cancer: a quantitative pilot study. Br J Surg 1990; 77: 93–96
  • Krasner N. Laser therapy in the management of benign and malignant tumours in the colon and rectum. Int J Colorectal Dis 1989; 4: 2–5
  • Barr H, Bown S G, Krasner N, Boulos PB. Photodynamic therapy for colorectal disease. Int J Colorectal Dis 1989; 4: 15–19
  • Monnier P, Savary M, Fontolliet C, et al. Photo-detection and photodynamic therapy of early squamous cell carcinomas of the pharynx, oesophagus and tracheo-bronchial tree. Lasers Med Sci 1990; 5: 149–168
  • Schweitzer V G, Visscher D. Photodynamic therapy for treatment of AIDS-related oral Kaposi's sarcoma. Otolaryngol Head Neck Surg 1990; 102: 639–649
  • Bugelski P J, Porter C W, Dougherty TJ. Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. Cancer Res 1981; 41: 4604–4612
  • Bellnier D A, Ho Y K, Pandey R K, Missert J R, Dougherty TJ. Distribution and elimination of Photofrin II in mice. Photochem Photobiol 1989; 59: 221–228
  • Schoenfeld N, Epstein O, Lahav M, Mamet R, Shaklai M, Atsmon A. The heme biosynthetic pathway in lymphocytes of patients with malignant lymphoproliferative disorders. Cancer Lett 1988; 43: 43–48
  • Leibovici L, Schoenfeld N IL, I, Yehoshua H A, et al. Activity of porphobilinogen deaminase in peripheral blood mononuclear cells of patients with metastatic cancer. Cancer 1988; 62: 2297–2300
  • Kennedy J C, Pottier R H, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photoch Photobio B 1990; 6: 143–148
  • Divaris D XG, Kennedy J C, Pottier RH. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol 1990; 136: 891–897
  • Nelson J S, Liaw L H, Lahlum R A, Cooper P L, Berns MW. Use of multiple photosensitizers and wavelengths during photodynamic therapy: a new approach to enhance tumor eradication. J Natl Cancer Inst 1990; 82: 868–873
  • Mang TS. Combination studies of hyperthermia induced by the neodymicum:yttrium-aluminium-Garnet (Nd: YAG) laser as an adjuvant to photo-dynamic therapy. Lasers Surg Med 1990; 10: 173–178
  • Calzavara F, Tomio L, Corti L, et al. Oesophageal cancer treated by photodynamic therapy alone or followed by radiation therapy. J Photochem Photobiol B 1990; 6: 167–174
  • Jin M L, Yang B Q, Zhang W, Ren P. Review of photodynamic therapy for gastrointestinal tumours in the past 6 years in China. J Photochem Photobiol B 1990; 7: 87–92

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.